vs
Side-by-side financial comparison of Five9, Inc. (FIVN) and AMICUS THERAPEUTICS, INC. (FOLD). Click either name above to swap in a different company.
Five9, Inc. is the larger business by last-quarter revenue ($300.3M vs $185.2M, roughly 1.6× AMICUS THERAPEUTICS, INC.). On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 7.8%). Five9, Inc. produced more free cash flow last quarter ($77.3M vs $16.0M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 10.3%).
Five9, Inc. is a leading global provider of cloud-native contact center software and solutions. It serves enterprises of all sizes across retail, healthcare, financial services, and technology sectors, offering omnichannel customer engagement tools, AI-powered automation, workforce management, and analytics to boost customer experience and operational efficiency.
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
FIVN vs FOLD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $300.3M | $185.2M |
| Net Profit | — | $1.7M |
| Gross Margin | 55.4% | 85.7% |
| Operating Margin | 6.6% | 8.6% |
| Net Margin | — | 0.9% |
| Revenue YoY | 7.8% | 23.7% |
| Net Profit YoY | — | -88.5% |
| EPS (diluted) | $0.22 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $300.3M | $185.2M | ||
| Q3 25 | $285.8M | $169.1M | ||
| Q2 25 | $283.3M | $154.7M | ||
| Q1 25 | $279.7M | $125.2M | ||
| Q4 24 | $278.7M | $149.7M | ||
| Q3 24 | $264.2M | $141.5M | ||
| Q2 24 | $252.1M | $126.7M | ||
| Q1 24 | $247.0M | $110.4M |
| Q4 25 | — | $1.7M | ||
| Q3 25 | $18.0M | $17.3M | ||
| Q2 25 | $1.2M | $-24.4M | ||
| Q1 25 | $576.0K | $-21.7M | ||
| Q4 24 | — | $14.7M | ||
| Q3 24 | $-4.5M | $-6.7M | ||
| Q2 24 | $-12.8M | $-15.7M | ||
| Q1 24 | $-7.1M | $-48.4M |
| Q4 25 | 55.4% | 85.7% | ||
| Q3 25 | 55.0% | 88.5% | ||
| Q2 25 | 54.9% | 90.2% | ||
| Q1 25 | 55.0% | 90.7% | ||
| Q4 24 | 56.0% | 90.1% | ||
| Q3 24 | 53.8% | 90.6% | ||
| Q2 24 | 53.0% | 91.1% | ||
| Q1 24 | 53.6% | 87.7% |
| Q4 25 | 6.6% | 8.6% | ||
| Q3 25 | 5.6% | 20.3% | ||
| Q2 25 | -0.6% | -6.1% | ||
| Q1 25 | -1.9% | -6.3% | ||
| Q4 24 | 1.5% | 10.7% | ||
| Q3 24 | -5.8% | 15.3% | ||
| Q2 24 | -7.7% | 11.8% | ||
| Q1 24 | -8.4% | -25.1% |
| Q4 25 | — | 0.9% | ||
| Q3 25 | 6.3% | 10.2% | ||
| Q2 25 | 0.4% | -15.8% | ||
| Q1 25 | 0.2% | -17.3% | ||
| Q4 24 | — | 9.8% | ||
| Q3 24 | -1.7% | -4.8% | ||
| Q2 24 | -5.1% | -12.4% | ||
| Q1 24 | -2.9% | -43.9% |
| Q4 25 | $0.22 | $0.00 | ||
| Q3 25 | $0.21 | $0.06 | ||
| Q2 25 | $0.01 | $-0.08 | ||
| Q1 25 | $0.01 | $-0.07 | ||
| Q4 24 | $0.16 | $0.05 | ||
| Q3 24 | $-0.06 | $-0.02 | ||
| Q2 24 | $-0.17 | $-0.05 | ||
| Q1 24 | $-0.10 | $-0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $232.1M | $293.5M |
| Total DebtLower is stronger | — | $392.7M |
| Stockholders' EquityBook value | $785.8M | $274.2M |
| Total Assets | $1.8B | $949.9M |
| Debt / EquityLower = less leverage | — | 1.43× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $232.1M | $293.5M | ||
| Q3 25 | $193.4M | $263.8M | ||
| Q2 25 | $205.5M | $231.0M | ||
| Q1 25 | $370.3M | $250.6M | ||
| Q4 24 | $362.5M | $249.9M | ||
| Q3 24 | $291.0M | $249.8M | ||
| Q2 24 | $175.7M | $260.1M | ||
| Q1 24 | $240.2M | $239.6M |
| Q4 25 | — | $392.7M | ||
| Q3 25 | — | $392.0M | ||
| Q2 25 | — | $391.3M | ||
| Q1 25 | — | $390.7M | ||
| Q4 24 | — | $390.1M | ||
| Q3 24 | — | $389.5M | ||
| Q2 24 | — | $388.9M | ||
| Q1 24 | — | $388.4M |
| Q4 25 | $785.8M | $274.2M | ||
| Q3 25 | $775.3M | $230.4M | ||
| Q2 25 | $717.4M | $204.3M | ||
| Q1 25 | $664.3M | $193.6M | ||
| Q4 24 | $622.2M | $194.0M | ||
| Q3 24 | $565.6M | $178.8M | ||
| Q2 24 | $525.9M | $132.5M | ||
| Q1 24 | $483.6M | $130.7M |
| Q4 25 | $1.8B | $949.9M | ||
| Q3 25 | $1.8B | $868.8M | ||
| Q2 25 | $1.7B | $815.3M | ||
| Q1 25 | $2.1B | $789.8M | ||
| Q4 24 | $2.1B | $785.0M | ||
| Q3 24 | $2.0B | $786.6M | ||
| Q2 24 | $1.9B | $749.5M | ||
| Q1 24 | $1.9B | $721.8M |
| Q4 25 | — | 1.43× | ||
| Q3 25 | — | 1.70× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.02× | ||
| Q4 24 | — | 2.01× | ||
| Q3 24 | — | 2.18× | ||
| Q2 24 | — | 2.93× | ||
| Q1 24 | — | 2.97× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $83.6M | $16.3M |
| Free Cash FlowOCF − Capex | $77.3M | $16.0M |
| FCF MarginFCF / Revenue | 25.8% | 8.6% |
| Capex IntensityCapex / Revenue | 2.1% | 0.2% |
| Cash ConversionOCF / Net Profit | — | 9.62× |
| TTM Free Cash FlowTrailing 4 quarters | $201.2M | $29.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $83.6M | $16.3M | ||
| Q3 25 | $59.2M | $35.7M | ||
| Q2 25 | $35.1M | $-26.5M | ||
| Q1 25 | $48.4M | $7.8M | ||
| Q4 24 | $49.8M | $-3.9M | ||
| Q3 24 | $41.1M | $-23.0M | ||
| Q2 24 | $19.9M | $22.7M | ||
| Q1 24 | $32.4M | $-29.7M |
| Q4 25 | $77.3M | $16.0M | ||
| Q3 25 | $48.7M | $35.3M | ||
| Q2 25 | $31.6M | $-28.9M | ||
| Q1 25 | $43.7M | $7.5M | ||
| Q4 24 | $40.5M | $-4.2M | ||
| Q3 24 | $26.7M | $-23.3M | ||
| Q2 24 | $13.1M | $21.6M | ||
| Q1 24 | $20.4M | $-31.5M |
| Q4 25 | 25.8% | 8.6% | ||
| Q3 25 | 17.0% | 20.9% | ||
| Q2 25 | 11.1% | -18.7% | ||
| Q1 25 | 15.6% | 6.0% | ||
| Q4 24 | 14.5% | -2.8% | ||
| Q3 24 | 10.1% | -16.5% | ||
| Q2 24 | 5.2% | 17.0% | ||
| Q1 24 | 8.3% | -28.5% |
| Q4 25 | 2.1% | 0.2% | ||
| Q3 25 | 3.7% | 0.2% | ||
| Q2 25 | 1.2% | 1.6% | ||
| Q1 25 | 1.7% | 0.2% | ||
| Q4 24 | 3.3% | 0.2% | ||
| Q3 24 | 5.4% | 0.3% | ||
| Q2 24 | 2.7% | 0.9% | ||
| Q1 24 | 4.8% | 1.6% |
| Q4 25 | — | 9.62× | ||
| Q3 25 | 3.29× | 2.06× | ||
| Q2 25 | 30.38× | — | ||
| Q1 25 | 84.00× | — | ||
| Q4 24 | — | -0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FIVN
Segment breakdown not available.
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
